Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Mar 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4965134015 | Alogliptin and metformin only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4965135019 | Product containing only alogliptin and metformin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2853191000001114 | Alogliptin + Metformin (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2853201000001111 | Alogliptin + Metformin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Alogliptin + Metformin | Is a | Product containing alogliptin and metformin (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Alogliptin + Metformin | Has active ingredient | Metformin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Alogliptin + Metformin | Has active ingredient | Alogliptin | true | Inferred relationship | Existential restriction modifier | 2 | |
| Alogliptin + Metformin | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only alogliptin and metformin in oral dose form (medicinal product form) | Is a | True | Alogliptin + Metformin | Inferred relationship | Existential restriction modifier | |
| Alogliptin 12.5mg / Metformin 1g tablets | Is a | True | Alogliptin + Metformin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR